Event lands · filed 2026-09-08
Boston Scientific: Form 8-K Item 1.05
Identified 2026-08-25. Disclosed 2026-08-26. Filed 2026-09-08.
Disclosure excerpt
As previously disclosed in a Current Report on Form 8-K filed on August 26, 2026 with the Securities and Exchange Commission, on August 25, 2026, Boston Scientific Corporation (the “ Company ”) identified a cybersecurity incident that affected certain of its information technology systems and resulted in a global disruption to the Company’s operations. Upon detection, the Company activated its incident response protocols, and since then has been working, with the assistance of third-party cybersecurity experts, to investigate, assess and contain the impact of the incident and to restore operations. The incident involved unauthorized activity on certain of the Company’s systems that resulted in a network outage affecting access to certain operating systems and business applications, which impacted the Company’s ability to manufacture as well as process and ship customer orders. As of the date of this Current Report on Form 8-K, the Company has not identified evidence of ongoing unauthorized access to its systems. The Company’s investigation of the incident remains ongoing.
Verbatim match to filing. Filing 0000885725-26-000059 · content sha256 8109f921ec1e
Quoted text is exempt from the vocabulary guard and tagged as quoted. Excerpt checked as an exact substring in code.
Structured incident
extraction_system.v2
| Field | Value | Provenance |
|---|---|---|
| incident_type | unknown | Derived |
| attack_vector | unknown | Derived |
| systems_affected | certain information technology systems, certain operating systems and business applications, network, distribution network, manufacturing, order processing and shipping | Derived |
| data_types_compromised | unknown | Derived |
| operational_status | partial_disruption | Derived |
| regulatory_obligations | unknown | Derived |
| third_party_impact | Needs analyst input | Derived |
| discovery_date | 2026-08-25 | Derived |
| disclosure_date | 2026-08-26 | Derived |
| containment_status | ongoing | Derived |
| discovery_to_disclosure_days | 1 | Derived |
| unknown_fields | incident_type, attack_vector, data_types_compromised, regulatory_obligations, third_party_impact | Derived |
| event_class | cyber_incident | Derived |
Analyst review
| Incident | Field | Model value | Confirmed value | Reviewed (UTC) | Note |
|---|---|---|---|---|---|
| Amgen2026-07-31 | operational_status | fully_operational Analyst-confirmed | 2026-10-19 22:13:02 | Filing: "To date, the Company has not identified any impact to its products, manufacturing operations, or financial reporting systems, or to the Company's ability to meet patient needs." Amgen Form 8-K, Item 1.05. Reviewer: Shaunak. |